ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 001,80
-0,48%
Dow Jones
38 798,99
-0,22%
DAX
18 557,27
-0,48%
Brent Oil
79,395
-0,61%
Bitcoin
69 261,63
-2,12%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Veracyte Inc (VCYT)

  7. Veracyte Inc (VCYT) Actualités

VCYT Veracyte Inc

20,65
-0,76 (-3,55%)
Après les heures de négociation
Dernière mise à jour : 22:44:50
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Veracyte Inc VCYT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,76 -3,55% 20,65 22:44:50
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
20,92 20,56 21,035 20,65 21,41
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
04/6/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:05BWVeracyte Announces that New Afirma GRID Data Suggest..
30/5/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:26EDGAR2Form 144 - Report of proposed sale of securities
22/5/202422:05BWVeracyte Announces Multiple Afirma GRID Presentations at..
15/5/202423:04BWVeracyte to Participate in Upcoming Investor Conferences
08/5/202423:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202422:10EDGAR2Form 8-K - Current report
07/5/202422:05BWVeracyte Announces First Quarter 2024 Financial Results
06/5/202422:05BW14 Studies Presented at AUA 2024 Show Decipher Tests’..
22/4/202423:00BWVeracyte to Release First Quarter 2024 Financial Results on..
22/4/202414:30BWNew Study Shows Veracyte’s Decipher Prostate Test is..
16/4/202414:30BWVeracyte Announces that Nine Studies Reinforcing the Value..
08/3/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:27EDGAR2Form 8-K - Current report
29/2/202423:22EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
29/2/202423:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202422:40EDGAR2Form S-3ASR - Automatic shelf registration statement of..
29/2/202414:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202423:55BWVeracyte’s Decipher Prostate Test Receives Highest..
22/2/202422:12EDGAR2Form 8-K - Current report
22/2/202422:05BWVeracyte Announces Fourth Quarter and Full-Year 2023..
21/2/202423:00BWVeracyte to Participate in the Raymond James 45th Annual..
13/2/202422:15EDGAR2Form 8-K - Current report
08/2/202414:00BWVeracyte to Release Fourth Quarter and Full-Year 2023..
06/2/202414:23EDGAR2Form 8-K - Current report
06/2/202414:15BWVeracyte Completes Acquisition of C2i Genomics
29/1/202422:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202414:12EDGAR2Form 8-K - Current report
08/1/202414:00BWVeracyte Announces Preliminary Full-Year 2023 Results,..
12/12/202322:30BWVeracyte to Participate in the 42nd Annual J.P. Morgan..
05/12/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
VCYT
Veracyte
NASDAQ
ZAAXOX
Accelkkr Structured Capi...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés